Cargando…
Clinical efficacy, safety and tolerability of aliskiren monotherapy: a protocol for an umbrella review
INTRODUCTION: Aliskiren is a newly developed medicine. As one of the effective renin–angiotensin–aldosterone system inhibitors, its role in lowering blood pressure has been recognised. However, its safety and tolerability still remain controversial. The aim of the paper is to systematically summaris...
Autores principales: | Zhao, Qiyuan, Shen, Jiantong, Lu, Jingya, Li, Fan, Jiang, Qi, Wang, Yuanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045264/ https://www.ncbi.nlm.nih.gov/pubmed/31969367 http://dx.doi.org/10.1136/bmjopen-2019-033448 |
Ejemplares similares
-
Clinical efficacy, safety and tolerability of Aliskiren Monotherapy (AM): an umbrella review of systematic reviews
por: Zhao, Qiyuan, et al.
Publicado: (2020) -
Efficacy and safety of aliskiren combination therapy: a protocol for an umbrella review
por: Shen, Jiantong, et al.
Publicado: (2021) -
Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: protocol for an umbrella review
por: Elliott, Jesse, et al.
Publicado: (2017) -
Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis
por: Liu, Di, et al.
Publicado: (2023) -
Quality of the Evidence Supporting the Role of Acupuncture for Stable Angina Pectoris: An Umbrella Review of Systematic Reviews
por: Shen, Min, et al.
Publicado: (2021)